| 摘要 |
1. Technical Result Increase in treatment efficiency and widening of the medicinal means containing HIV protease inhibitor. 2. Essence Pharmaceutical formulations containing HIV protease inhibitors, specifically including 3S-[3R*(1R*,2S*)]-[3-[[(4-aminophenyl)sulphonyl] (2-methylpropyl) - amino] - 2-hydrxy-1-phenylmethyl) propyl] carbamic acid, tetrahydro-3-furanyl ester (alternatively known as VX 478 or 141 W94), and a tocopherol. 3. Field of Application Medicine, therapy. Tables: 3 Figures: 1 |
